E-LIB Suche - Ergebnisse für: Jarvis, Philip

1

Interleukin-17A blockade with secukinumab results in decrea..:

Loesche, Christian ; Kolbinger, Frank ; Valentin, Marie-Anne...
Advances in Precision Medicine. 1 (2023) 2 - p. , 2023

2

IL‐17A is a pertinent therapeutic target for moderate‐to‐se..:

Kimball, Alexa B. ; Loesche, Christian ; Prens, Errol P....
Experimental Dermatology. 31 (2022) 10 - p. 1522-1532 , 2022

Link: https://doi.org/10.1111/..

3

Demystifying the radiology gatekeeper: How often do radiolo..:

George, Anthony ; Jarvis, Philip
Clinical Radiology. 77 (2022) - p. e25-e26 , 2022

Link: https://doi.org/10.1016/..

4

A Multicentre, Double-Blind, Placebo-Controlled, Parallel-G..:

Radeke, Heinfried H. ; Stein, Jürgen ; Van Assche, Gert...
Inflammatory Intestinal Diseases. 5 (2020) 4 - p. 180-190 , 2020

Link: https://doi.org/10.1159/..

5

Secukinumab Demonstrates Significantly Lower Immunogenicity..:

Spindeldreher, Sebastian ; Maillère, Bernard ; Correia, Evelyne...
Dermatology and Therapy. 8 (2018) 1 - p. 57-68 , 2018

Link: https://doi.org/10.1007/..

6

Author Correction: Secukinumab Demonstrates Significantly L..:

Spindeldreher, Sebastian ; Maillère, Bernard ; Correia, Evelyne...
Dermatology and Therapy. 8 (2018) 2 - p. 327-327 , 2018

Link: https://doi.org/10.1007/..

7

β-Defensin 2 is a responsive biomarker of IL-17A–driven ski..:

Kolbinger, Frank ; Loesche, Christian ; Valentin, Marie-Anne...
Journal of Allergy and Clinical Immunology. 139 (2017) 3 - p. 923-932.e8 , 2017

Link: https://doi.org/10.1016/..

8

Clinical efficacy of omalizumab in chronic spontaneous urti..:

Metz, Martin ; Staubach, Petra ; Bauer, Andrea...
Theranostics. 7 (2017) 5 - p. 1266-1276 , 2017

Link: https://doi.org/10.7150/..

9

Assessing the predictive value of the rodent neurofunctiona..:

Mead, Andy N. ; Amouzadeh, Hamid R. ; Chapman, Kathryn...
Regulatory Toxicology and Pharmacology. 80 (2016) - p. 348-357 , 2016

Link: https://doi.org/10.1016/..

10

The predictive value of the rodent neurofunctional assessme..:

Mead, Andrew ; Amouzadeh, Hamid ; Chapman, Kathryn...
Journal of Pharmacological and Toxicological Methods. 81 (2016) - p. 375 , 2016

Link: https://doi.org/10.1016/..

11

The Concordance between Nonclinical and Phase I Clinical Ca..:

Ewart, Lorna ; Aylott, Mike ; Deurinck, Mark...
Toxicological Sciences. 142 (2014) 2 - p. 427-435 , 2014

Link: https://doi.org/10.1093/..

12

On the Relationship between Molecular Hit Rates in High-Thr..:

Hansson, Mari ; Pemberton, John ; Engkvist, Ola...
SLAS Discovery. 19 (2014) 5 - p. 727-737 , 2014

Link: https://doi.org/10.1177/..

13

Translational pharmacokinetic–pharmacodynamic modeling of Q..:

Parkinson, Joanna ; Visser, Sandra A.G. ; Jarvis, Philip...
Journal of Pharmacological and Toxicological Methods. 68 (2013) 3 - p. 357-366 , 2013

Link: https://doi.org/10.1016/..

14

Phosphorus and sulfur metabonomic profiling of tissue and p..:

Thompson, David F. ; Michopoulos, Filippos ; Smith, Christopher J....
Rapid Communications in Mass Spectrometry. 27 (2013) 22 - p. 2539-2545 , 2013

Link: https://doi.org/10.1002/..

15

An assessment of the statistical methods used to analyse to..:

Jarvis, Philip ; Saul, Jim ; Aylott, Mike...
Pharmaceutical Statistics. 10 (2011) 6 - p. 477-484 , 2011

Link: https://doi.org/10.1002/..